Breaking News, Collaborations & Alliances

IRX Therapeutics Enters Research Collaboration


IRX Therapeutics has signed a research collaboration agreement with a leading research-based pharmaceutical company to assess the potential effects of IRX-2 on the tumor microenvironment.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

IRX Therapeutics has signed a research collaboration agreement with a leading research-based pharmaceutical company to assess the potential effects of IRX-2 on the tumor microenvironment. Tumor specimens from subjects treated with IRX-2 and control subjects will be analyzed using gene analysis technology to characterize the action of IRX-2 immunotherapy at the molecular level. IRX-2 is designed to broadly restore the immune system to overcome cancer–induced immune suppression and restore an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters